SLU-PP-332 is a small-molecule REV-ERB agonist studied for its role in regulating circadian rhythm and enhancing mitochondrial activity. It acts on REV-ERBα and REV-ERBβ nuclear receptors, which are key regulators of lipid metabolism, energy balance, and biological clock signaling.

SLU-PP-332 is commonly used in research settings focused on metabolic pathways, circadian biology, and energy utilization. It is incorporated into studies examining fat oxidation, mitochondrial performance, and metabolic efficiency.

SLU-PP-332 is associated with increased energy expenditure, enhanced fat oxidation, and improved metabolic signaling. Its role in circadian modulation also supports research into sleep-wake regulation, hormonal balance, and overall energy homeostasis.

SLU-PP-332 is ideal for researchers and individuals exploring obesity-related pathways, metabolic health, weight management, and advanced studies in circadian and mitochondrial biology.